List of Publicly Traded Biotech and Pharmaceutical Companies Headquartered in California
The companies on this list are biotech and pharmaceutical companies headquartered in California. Examples of some of the larger companies on this list based on market capitalization include:
BioMarin Pharmaceutical Inc. (BMRN)
Resources:
Additional publicly traded companies in California can be accessed through the link below
Publicly Traded Companies in California
Select the company’s link to access charts, news links and company website and social media information.
ACADIA Pharmaceuticals Inc. (ACAD) (Biopharmaceutical company: central nervous system disorders)
AcelRx Pharmaceuticals, Inc. (ACRX) (Therapies for the treatment of acute pain)
Achaogen, Inc. (AKAO) (Biopharmaceutical company: antibacterials to treat multi-drug resistant gram-negative infections)
Adamas Pharmaceuticals, Inc. (ADMS) (Chronic disorders of the central nervous system)
Adamis Pharmaceuticals Corporation (ADMP) (Respiratory disease, allergy)
Aduro BioTech, Inc. (ADRO) (Cancer immunotherapy; pancreatic cancer)
Adverum Biotechnologies, Inc. (ADVM) (Biopharmaceutical company: serious eye diseases)
Aimmune Therapeutics, Inc. (AIMT) (Biopharmaceutical company: allergies)
Amgen Inc. (AMGN) (Therapeutics: cardiovascular, inflammation, oncology, biosimilars)
Amphastar Pharmaceuticals, Inc. (AMPH) (Generic and branded injectable and inhalation products)
AnaptysBio, Inc. (ANAB) (IPO January 26, 2017; biotech company; inflammation)
Apricus Biosciences, Inc. (APRI) (Biopharmaceutical company: sexual health therapies, urology and rheumatology)
Aradigm Corporation (ARDM) (Severe respiratory disease)
Arcturus Therapeutics (ARCT) (RNA medicines and technologies)
Arcus Biosciences, Inc. (RCUS) (IPO March 15, 2018; biopharmaceutical company: cancer immunotherapies)
Ardelyx, Inc. (ARDX) (Molecule therapeutics: gastrointestinal)
Arena Pharmaceuticals, Inc. (ARNA) (Biopharmaceutical company: drugs that target G protein-coupled receptors; weight management)
ARMO BioSciences, Inc. (ARMO) (IPO January 26, 2018; immuno-oncology company)
Arrowhead Research Corporation (ARWR) (Biopharmaceutical company: RNAi therapeutics, chronic hepatitis B infection)
Asterias Biotherapeutics, Inc. (AST) (Biotechnology company: regenerative medicine; therapeutics developed from platforms based on pluripotent stem cells and dendritic cell cancer immunotherapy)
Atara Biotherapeutics, Inc. (ATRA) (Molecularly-targeted product candidates and T-cell product candidates; cancer, kidney disease and other illnesses)